Observational Sutdy to Assess the Effectiveness of Avodart in Subjects With Benign Prostatic Hyperplasia in Day to Day Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms OASIS
- Sponsors GlaxoSmithKline
- 09 Oct 2008 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 23 Nov 2006 New trial record.